These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 10493495

  • 1. Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells.
    Ebert AD, Wechselberger C, Frank S, Wallace-Jones B, Seno M, Martinez-Lacaci I, Bianco C, De Santis M, Weitzel HK, Salomon DS.
    Cancer Res; 1999 Sep 15; 59(18):4502-5. PubMed ID: 10493495
    [Abstract] [Full Text] [Related]

  • 2. Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes.
    Tang Q, Gonzales M, Inoue H, Bowden GT.
    Cancer Res; 2001 Jun 01; 61(11):4329-32. PubMed ID: 11389054
    [Abstract] [Full Text] [Related]

  • 3. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation.
    Chen EY, Mazure NM, Cooper JA, Giaccia AJ.
    Cancer Res; 2001 Mar 15; 61(6):2429-33. PubMed ID: 11289110
    [Abstract] [Full Text] [Related]

  • 4. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity.
    Bijur GN, Jope RS.
    J Neurochem; 2000 Dec 15; 75(6):2401-8. PubMed ID: 11080191
    [Abstract] [Full Text] [Related]

  • 5. Akt/protein kinase B isoforms are differentially regulated by epidermal growth factor stimulation.
    Okano J, Gaslightwala I, Birnbaum MJ, Rustgi AK, Nakagawa H.
    J Biol Chem; 2000 Oct 06; 275(40):30934-42. PubMed ID: 10908564
    [Abstract] [Full Text] [Related]

  • 6. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase.
    Gold MR, Scheid MP, Santos L, Dang-Lawson M, Roth RA, Matsuuchi L, Duronio V, Krebs DL.
    J Immunol; 1999 Aug 15; 163(4):1894-905. PubMed ID: 10438924
    [Abstract] [Full Text] [Related]

  • 7. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells.
    Panka DJ, Mano T, Suhara T, Walsh K, Mier JW.
    J Biol Chem; 2001 Mar 09; 276(10):6893-6. PubMed ID: 11145953
    [Abstract] [Full Text] [Related]

  • 8. The effects of clozapine on the GSK-3-mediated signaling pathway.
    Kang UG, Seo MS, Roh MS, Kim Y, Yoon SC, Kim YS.
    FEBS Lett; 2004 Feb 27; 560(1-3):115-9. PubMed ID: 14988008
    [Abstract] [Full Text] [Related]

  • 9. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation.
    Rössig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S.
    J Biol Chem; 2002 Mar 22; 277(12):9684-9. PubMed ID: 11779850
    [Abstract] [Full Text] [Related]

  • 10. Alleviating the suppression of glycogen synthase kinase-3beta by Akt leads to the phosphorylation of cAMP-response element-binding protein and its transactivation in intact cell nuclei.
    Salas TR, Reddy SA, Clifford JL, Davis RJ, Kikuchi A, Lippman SM, Menter DG.
    J Biol Chem; 2003 Oct 17; 278(42):41338-46. PubMed ID: 12900420
    [Abstract] [Full Text] [Related]

  • 11. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3beta signaling pathway.
    Pap M, Cooper GM.
    Mol Cell Biol; 2002 Jan 17; 22(2):578-86. PubMed ID: 11756553
    [Abstract] [Full Text] [Related]

  • 12. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C, Blivet-Van Eggelpoël MJ, Beurel E, Boissan M, Delélo R, Cadoret A, Capeau J.
    Hepatology; 2002 Dec 17; 36(6):1528-36. PubMed ID: 12447879
    [Abstract] [Full Text] [Related]

  • 13. Peroxynitrite activates the phosphoinositide 3-kinase/Akt pathway in human skin primary fibroblasts.
    Klotz LO, Schieke SM, Sies H, Holbrook NJ.
    Biochem J; 2000 Nov 15; 352 Pt 1(Pt 1):219-25. PubMed ID: 11062076
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclic AMP promotes neuronal survival by phosphorylation of glycogen synthase kinase 3beta.
    Li M, Wang X, Meintzer MK, Laessig T, Birnbaum MJ, Heidenreich KA.
    Mol Cell Biol; 2000 Dec 15; 20(24):9356-63. PubMed ID: 11094086
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
    Liang Y, Jing Z, Deng H, Li Z, Zhuang Z, Wang S, Wang Y.
    Biochem Biophys Res Commun; 2000 Dec 15; 463(1-2):70-5. PubMed ID: 25986738
    [Abstract] [Full Text] [Related]

  • 19. Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway.
    Fang X, Yu S, Tanyi JL, Lu Y, Woodgett JR, Mills GB.
    Mol Cell Biol; 2002 Apr 15; 22(7):2099-110. PubMed ID: 11884598
    [Abstract] [Full Text] [Related]

  • 20. Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells.
    Normanno N, De Luca A, Bianco C, Maiello MR, Carriero MV, Rehman A, Wechselberger C, Arra C, Strizzi L, Sanicola M, Salomon DS.
    J Cell Physiol; 2004 Jan 15; 198(1):31-9. PubMed ID: 14584041
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.